BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38438647)

  • 1. Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT.
    Passweg JR; Baldomero H; Ciceri F; de la Cámara R; Glass B; Greco R; Hazenberg MD; Kalwak K; McLornan DP; Neven B; Perić Z; Risitano AM; Ruggeri A; Snowden JA; Sureda A
    Bone Marrow Transplant; 2024 Jun; 59(6):803-812. PubMed ID: 38438647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey.
    Passweg JR; Baldomero H; Ciceri F; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; McLornan DP; Neven B; de Latour RP; Perić Z; Ruggeri A; Snowden JA; Sureda A
    Bone Marrow Transplant; 2023 Jun; 58(6):647-658. PubMed ID: 36879108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.
    Passweg JR; Baldomero H; Chabannon C; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; Mohty M; Neven B; Peffault de Latour R; Perić Z; Snowden JA; Yakoub-Agha I; Sureda A; Kröger N;
    Bone Marrow Transplant; 2022 May; 57(5):742-752. PubMed ID: 35194156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.
    Passweg JR; Baldomero H; Bader P; Basak GW; Bonini C; Duarte R; Dufour C; Kröger N; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M;
    Bone Marrow Transplant; 2018 Sep; 53(9):1139-1148. PubMed ID: 29540849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.
    Passweg JR; Baldomero H; Chabannon C; Basak GW; de la Cámara R; Corbacioglu S; Dolstra H; Duarte R; Glass B; Greco R; Lankester AC; Mohty M; Peffault de Latour R; Snowden JA; Yakoub-Agha I; Kröger N;
    Bone Marrow Transplant; 2021 Jul; 56(7):1651-1664. PubMed ID: 33623153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.
    Passweg JR; Baldomero H; Chabannon C; Basak GW; Corbacioglu S; Duarte R; Dolstra H; Lankester AC; Mohty M; Montoto S; Peffault de Latour R; Snowden JA; Styczynski J; Yakoub-Agha I; Kröger N;
    Bone Marrow Transplant; 2020 Aug; 55(8):1604-1613. PubMed ID: 32066864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.
    Passweg JR; Baldomero H; Basak GW; Chabannon C; Corbacioglu S; Duarte R; Kuball J; Lankester A; Montoto S; de Latour RP; Snowden JA; Styczynski J; Yakoub-Agha I; Arat M; Mohty M; Kröger N;
    Bone Marrow Transplant; 2019 Oct; 54(10):1575-1585. PubMed ID: 30728439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
    Passweg JR; Baldomero H; Bader P; Bonini C; Duarte RF; Dufour C; Gennery A; Kröger N; Kuball J; Lanza F; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M
    Bone Marrow Transplant; 2017 Jun; 52(6):811-817. PubMed ID: 28287639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012.
    Correa C; Gonzalez-Ramella O; Baldomero H; Basquiera AL; Baena R; Arcuri L; Puga B; Rosales C; Chávez M; Hernández C; Maldonado B; Gómez-De León A; Mendoza N; Frutos C; Aranda L; Díaz L; Hernández M; Seber A; Karduss A; Jaimovich G; Martínez-Rolon J; Bonfim C; Greinix H; Koh MBC; Aljurf M; Iida M; Saber W; Niederwieser D; Atsuta Y; Galeano S; ;
    Bone Marrow Transplant; 2022 Jun; 57(6):881-888. PubMed ID: 35347244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EBMT activity survey: 1990-2010.
    Passweg JR; Baldomero H; Gratwohl A; Bregni M; Cesaro S; Dreger P; de Witte T; Farge-Bancel D; Gaspar B; Marsh J; Mohty M; Peters C; Tichelli A; Velardi A; de Elvira CR; Falkenburg F; Sureda A; Madrigal A;
    Bone Marrow Transplant; 2012 Jul; 47(7):906-23. PubMed ID: 22543746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
    Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M
    Bone Marrow Transplant; 2016 Jun; 51(6):786-92. PubMed ID: 26901709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.
    Bazarbachi A; Labopin M; Ghavamzadeh A; Giebel S; Al-Zahrani H; Ladeb S; Leone G; Abdel-Rahman F; Liso V; Hamidieh AA; Rasheed W; Ibrahim A; Alabdulaaly A; Kyrcz-Krzemien S; Arnold R; Kharfan-Dabaja MA; Alimoghaddam K; Aljurf M; Mohty M
    Bone Marrow Transplant; 2013 Aug; 48(8):1065-9. PubMed ID: 23353802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021.
    Passweg JR; Baldomero H; Ansari M; Arber C; Chalandon Y; Daskalakis M; Diepold M; Diesch-Furlanetto T; Duchosal MA; Gerull S; Güngör T; Heim D; Hitz F; Holbro A; Masouridi-Levrat S; Nair G; Novak U; Pabst T; Renner C; Stussi G; Schneidawind D; Schanz U; Wannesson L; Halter JP;
    Hematol Oncol; 2024 Jan; 42(1):e3241. PubMed ID: 38058031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EBMT activity survey 2009: trends over the past 5 years.
    Baldomero H; Gratwohl M; Gratwohl A; Tichelli A; Niederwieser D; Madrigal A; Frauendorfer K;
    Bone Marrow Transplant; 2011 Apr; 46(4):485-501. PubMed ID: 21358689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
    Niederwieser D; Baldomero H; Bazuaye N; Bupp C; Chaudhri N; Corbacioglu S; Elhaddad A; Frutos C; Galeano S; Hamad N; Hamidieh AA; Hashmi S; Ho A; Horowitz MM; Iida M; Jaimovich G; Karduss A; Kodera Y; Kröger N; Péffault de Latour R; Lee JW; Martínez-Rolón J; Pasquini MC; Passweg J; Paulson K; Seber A; Snowden JA; Srivastava A; Szer J; Weisdorf D; Worel N; Koh MBC; Aljurf M; Greinix H; Atsuta Y; Saber W
    Haematologica; 2022 May; 107(5):1045-1053. PubMed ID: 34382386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1999 Aug; 24(3):231-45. PubMed ID: 10456992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.